 | • レポートコード：MRC2303A075 • 出版社/出版日：Persistence Market Research / 2022年12月16日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社発行の当調査レポートでは、世界の臨床試験キット市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、市場背景、市場分析・予測、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、サービス別（キッティングソリューション、物流）、フェーズ別（フェーズI、フェーズII、フェーズIII、フェーズIV）、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ）の情報が含まれています。なお、当市場の主要企業には、Azenta Life Sciences、Q2 Solutions、Patheon (Thermo fisher scientific)、LabCorp drug development、Charles River Laboratories、LabConnect、Almac group、Precision medicine group、Cerba research、Alpha Laboratories Ltd、Marken SAS、Clinigenなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場背景 ・市場分析・予測 ・世界の臨床試験キット市場規模： サービス別 - キッティングソリューションサービスの市場規模 - 物流サービスの市場規模 ・世界の臨床試験キット市場規模：フェーズ別 - フェーズIの市場規模 - フェーズIIの市場規模 - フェーズIIIの市場規模 - フェーズIVの市場規模 ・世界の臨床試験キット市場規模：地域別 - 北米の臨床試験キット市場規模 - 中南米の臨床試験キット市場規模 - ヨーロッパの臨床試験キット市場規模 - アジア太平洋の臨床試験キット市場規模 - 中東/アフリカの臨床試験キット市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Global Clinical Trial Kits Market: Global Industry Analysis 2015-2021 and Opportunity Assessment 2022-2032
A recent market study published by Persistence Market Research on the Clinical Trial Kits Market offers global industry analysis for 2015-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Clinical Trial Kits Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Service Type
Kitting Solutions
Drugs Kits
Sample Collection Kits
Logistics
Transportation
Warehousing & Storage
Other Logistics
By Phase
Phase I
Phase II
Phase III
Phase IV
By Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)
Report Chapters
Chapter 01 – Executive Summary
The executive summary of the Clinical Trial Kits Market includes the global market analysis, demand-side and supply-side trends, opportunity assessment, and recommendations on the global Clinical Trial Kits Market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the Clinical Trial Kits Market in this chapter, which will help them understand basic information about the Clinical Trial Kits Market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the Clinical Trial Kits Market report.
Chapter 03 – Market Background
The associated industry assessment of the global Clinical Trial Kits Market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the global Clinical Trial Kits Market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis, social media sentiment analysis, and consumer behavior analysis for the market. It offers provides key market dynamics of the Clinical Trial Kits Market, which include drivers, restraints, and opportunities.
Chapter 04 – Global Clinical Trial Kits Market Demand Analysis 2015-2021 and Forecast, 2022-2032
This section provides detailed analysis of the historical custom Clinical Trial Kits Market value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2021–2022) and an absolute opportunity for the forecast period (2022–2032).
Chapter 05 – Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, by Service Type
Based on Service Type, the Clinical Trial Kits Market is segmented into Kitting Solutions (Drugs kits, Sample collection kits), Logistics (Transportation, Warehousing & Storage, Other Logistics). In this chapter, readers can find market attractiveness analysis, based on Service Type.
Chapter 06 – Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, by Phase
This chapter provides details about the Clinical Trial Kits Market on the basis of phase which is segmented into Phase I, Phase II, Phase III, Phase IV, along with market attractiveness analysis.
Chapter 07 – Global Clinical Trial Kits Market Analysis 2015-2021 and Opportunity Assessment 2022-2032 by Region
This chapter explains how the Clinical Trial Kits Market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA).
Chapter 08 – North America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Clinical Trial Kits Market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth in the North America region.
Chapter 09 – Latin America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Clinical Trial Kits Market in the Latin America region. This chapter also includes growth prospects of the Clinical Trial Kits Market in leading LATAM countries such as Brazil, Mexico, Argentina and Rest of Latin America.
Chapter 10 – Europe Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
Important growth prospects of the Clinical Trial Kits Market in several countries such as Germany, Italy, France, U.K., Spain, Belgium and Rest of Europe are included in this chapter.
Chapter 11 –Asia Pacific Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Clinical Trial Kits Market in the Asia Pacific region, along with a country-wise assessment that includes China, Japan, South Korea, India, Australia and rest of Asia Pacific. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.
Chapter 12 – Middle East and Africa Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
This chapter offers insights into how the Clinical Trial Kits Market is expected to grow in major countries in the MEA region such as South Africa, Saudi Arabia, UAE and Rest of MEA, during the forecast period 2022-2032.
Chapter 13 – Key Countries Clinical Trial Kits Market Analysis
This chapter offers insights into how the Clinical Trial Kits Market is expected to grow in key countries such as U.S., Canada, Brazil, Mexico, Argentina, Germany, Italy, France, U.K., Spain, Belgium, China, Japan, South Korea, India, Australia, Saudi Arabia, South Africa, U.A.E. during the forecast period 2022-2032.
Chapter 14 – Market Structure Analysis
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the Clinical Trial Kits Market along with their market presence analysis by region and product portfolio.
Chapter 15 – Competition Analysis
In this chapter, readers can find a comprehensive list of manufacturers/ players in Clinical Trial Kits Market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report include Azenta Life Sciences, Q2 Solutions, Patheon, LabCorp drug development, Charles River Laboratories, LabConnect, Almac group, Precision medicine group, Cerba research, Alpha Laboratories Ltd, Marken SAS, Clinigen, among others.
Chapter 16 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Clinical Trial Kits Market report.
Chapter 17 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the Clinical Trial Kits Market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2015-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Service Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Service Type, 2015-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service Type, 2022-2032
5.3.1. Kitting Solutions
5.3.1.1. Drugs kits
5.3.1.2. Sample collection kits
5.3.2. Logistics
5.3.2.1. Transportation
5.3.2.2. Warehousing & Storage
5.3.2.3. Other Logistics
5.4. Y-o-Y Growth Trend Analysis By Service Type, 2015-2021
5.5. Absolute $ Opportunity Analysis By Service Type, 2022-2032
6. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Phase
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Phase, 2015-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Phase, 2022-2032
6.3.1. Phase I
6.3.2. Phase II
6.3.3. Phase III
6.3.4. Phase IV
6.4. Y-o-Y Growth Trend Analysis By Phase, 2015-2021
6.5. Absolute $ Opportunity Analysis By Phase, 2022-2032
7. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2015-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Service Type
8.2.3. By Phase
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Service Type
8.3.3. By Phase
8.4. Key Takeaways
9. Latin America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Service Type
9.2.3. By Phase
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Service Type
9.3.3. By Phase
9.4. Key Takeaways
10. Europe Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Service Type
10.2.3. By Phase
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Service Type
10.3.3. By Phase
10.4. Key Takeaways
11. Asia Pacific Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. Rest of Asia Pacific
11.2.2. By Service Type
11.2.3. By Phase
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Service Type
11.3.3. By Phase
11.4. Key Takeaways
12. MEA Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Service Type
12.2.3. By Phase
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Service Type
12.3.3. By Phase
12.4. Key Takeaways
13. Key Countries Clinical Trial Kits Market Analysis
13.1. U.K.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Service Type
13.1.2.2. By Phase
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Service Type
13.2.2.2. By Phase
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Service Type
13.3.2.2. By Phase
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Service Type
13.4.2.2. By Phase
13.5. Rest of Latin America
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Service Type
13.5.2.2. By Phase
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Service Type
13.6.2.2. By Phase
13.7. U.K.
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Service Type
13.7.2.2. By Phase
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Service Type
13.8.2.2. By Phase
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Service Type
13.9.2.2. By Phase
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Service Type
13.10.2.2. By Phase
13.11. Rest of Europe
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Service Type
13.11.2.2. By Phase
13.12. China
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Service Type
13.12.2.2. By Phase
13.13. Japan
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Service Type
13.13.2.2. By Phase
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Service Type
13.14.2.2. By Phase
13.15. Malaysia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Service Type
13.15.2.2. By Phase
13.16. Singapore
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Service Type
13.16.2.2. By Phase
13.17. Australia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Service Type
13.17.2.2. By Phase
13.18. Rest of Asia Pacific
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Service Type
13.18.2.2. By Phase
13.19. GCC Countries
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Service Type
13.19.2.2. By Phase
13.20. South Africa
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Service Type
13.20.2.2. By Phase
13.21. Israel
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2021
13.21.2.1. By Service Type
13.21.2.2. By Phase
13.22. Rest of MEA
13.22.1. Pricing Analysis
13.22.2. Market Share Analysis, 2021
13.22.2.1. By Service Type
13.22.2.2. By Phase
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Service Type
14.3.3. By Phase
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Azenta Life Sciences
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Q2 Solutions
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Patheon (Thermo fisher scientific)
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. LabCorp drug development
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Charles River Laboratories
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. LabConnect
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Almac group
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Precision medicine group
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Cerba research
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Alpha Laboratories Ltd
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. Marken SAS
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.12. Clinigen
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
